The EU's increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised ...

A South Bay biotech firm has bought a big San Jose office and research building in a deal that could enable the life sciences firm to expand its local operations considerably. Vibrant Wellness has ...

The current market data shows that the economy of the United States is normalizing, especially with an active Federal Reserve ...

Legend Biotech jumped Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its panel at the Goldman Sachs Cell ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

“This is quite exciting,” said Dr. Shirish M. Gadgeel, a medical oncologist at the Henry Ford Cancer Institute in Detroit.

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

In an effort to expand its cash runway beyond 12 months, Prime Medicines has signed a deal with Bristol Myers Squibb worth a ...

As the medical supply giant expands at the Merchandise Mart, it has also inked one of the biggest new office deals in the ...

Novartis reports strong Q2 2024 sales, with Kesimpta and Pluvicto showing significant growth. Learn more about NVSEF stock ...